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Materials and Methods

General experimental procedures
Melting points were determined on a Fischer Johns apparatus and are uncorrected. IR spectra were recorded on a Mattson Galaxy series FT-IR 3000 spectrophotometer. UV spectra were recorded on a Cary 100 spectrophotometer. NMR spectra were recorded on a Bruker Avance 400 spectrometer (400 MHz for 1 H/100 MHz for 13 C) or Varian Gemini 300 spectrometer (75 MHz for 1 H MHz for 13 C) in CDCl 3 solution at ambient room temperature. Chemical shifts are expressed relative to TMS using internal standard or the residual solvent peak as a secondary reference. Accurate mass measurement was performed on a Micromass Q-TOF 2 hybrid quadrupole time-of-flight mass spectrometer, equipped with a Z-spray interface using reserpine as the external mass calibrant. High-resolution mass spectra were acquired on Agilent ESI-TOF or JEOL LC-Mate APCI mass spectrometers. Column chromatography was conducted using silica gel 60 (230-400 mesh). Thin layer chromatography and preparative TLC were conducted using pre-coated silica gel F254 plates. Reagent grade chemicals were obtained from commercial sources and used as received. Cell images were captured using a VWR Vista Vision Inverted
Microscope (Model 82026-630) equipped with a CCD DV-2B Digital Camera. Positive-control drugs [doxorubicin (purity ≥ 98% TLC), camptothecin (purity 95% HPLC), etoposide (purity 98% TLC), and vinblastine (purity ≥ 96% HPLC)] were purchased from Sigma. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) reagent and media regents were also purchased from Sigma.
Extraction and isolation
Ground stems of Abuta rufescens (5.4 kg) were extracted four times with methanol at room temperature for two weeks each time, and the methanolic extract was evaporated to dryness to give a dark gum (263 g). This gum was partitioned in four batches. The total volume of solvents and the weight of the different fractions are given below. The methanolic extract was suspended in methanol/water (9:1, 3.6 L), and the solvent partitioned according to known procedures to provide hexane (1.5 L, 4.2 g), chloroform (3.9 L, 45.4 g), and n-butanol (2.0 L, 62.7 g) soluble fractions [1] . The chloroform fraction (38.0 g) was dissolved in dichloromethane (750 mL, 2 batches) and extracted with 3 x 500 mL of 5% NaOH to remove phenols. Evaporation of the organics to dryness gave 4.81 g of non-phenolic compounds. The pH of the aqueous layer was adjusted to pH 9 by 1.5 M H 2 SO 4 , which resulted in 12.66 g of a precipitate of phenolic alkaloids. The extraction of the aqueous filtrate with CH 2 Cl 2 gave 3.1 g more of additional phenolics, which were combined with the precipitate. Column chromatography of the phenolic compounds on silica (240 g, 4.6 cm x 1.2 m column) was performed with gradient elution (500 mL fractions) using CH Fractions 12-15 from the original column of the phenolic compounds eluted with 95:5 CH 2 Cl 2 /CH 3 OH gave an orange to dark yellow solution which on evaporation (1.65 g) followed by column chromatography on silica (50 g, 2.5 x 66 cm, 75 mL fractions) gave cherry red solution in fraction 2 with 94:6 CH 2 Cl 2 /CH 3 OH which on evaporation followed by recrystallization from CH 2 Cl 2 /CH 3 OH gave fine yellow needless of telitoxine (10) (5.0 mg).
Fractions 6-7 gave a dark red solution which on evaporation followed by silica gel preparative plate with 95:5 CH 2 Cl 2 /CH 3 OH gave, after recrystallization from CH 2 Cl 2 /CH 3 OH, dark red needles of subsessiline (11) (3.4 mg).
Two portions of the cytotoxic non-phenolic fraction were subjected to column chromatography on basic alumina (activity I) as well as silica gel-60 column chromatography. The results for silica (250 g) are reported here. The non-phenolic fraction (2.16 g, 5 cm x 1.2 m, 500 mL fractions) gave a complex mixture of 8-9 compounds in fractions 6-9 eluted with 99:1 CH 2 Cl 2 /CH 3 OH including imeluteine (4), homomoschatoline (2), imenine (3), and lysicamine (5). By preparative TLC separations with CH 2 Cl 2 , 4 (1.0 mg) and 2 (16.0 mg) were isolated.
Recrystallization from methanol was required to get pure red-orange crystals of 3 (11.0 mg). 
Cell culture
Cell lines HCT-116 (human colon adenocarcinoma), ACHN (human renal carcinoma), and A549
(human lung carcinoma) were purchased from American Type Culture Collection (ATCC). All cells were grown in monolayer culture. The HCT-116 line was grown using McCoy's 5A
Medium (ATCC) supplemented with 10% fetal bovine serum (Hyclone Laboratories), penicillin/streptomycin solution (100 U/mL and 100 μg/mL, respectively), 240 U/mL nystatin suspension (Sigma) or amphotericin B (2.5 μg/mL), and 1% (w/v) L-glutamine. The ACHN cells were grown in Eagle's Minimum Essential Medium (ATCC) and supplemented as described above. A549 cells were grown as monolayers in F-12K medium (ATCC) supplemented as above.
Cells were maintained in logarithmic phase of growth in a humidified incubator with 5% CO 2 atmosphere at 37 o C.
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MTT assay for cytotoxicity
The protocol employed for the MTT assay was similar to that reported previously by Swaffar et al. [2] with modifications. Cells were trypsinized (0.05% trypsin and 0.53 mM EDTA) and counted with a hemocytometer. Viability was determined by trypan blue exclusion (only cells having a viability >90% were used for assays). Cell stocks were made as 5X suspensions at concentrations that varied for each cell line. Prior to testing any extracts and isolated compounds, Plates were then incubated in a humidified 5% CO 2 atmosphere at 37 o C for at least 4 hours to allow the cells to adhere. All extracts, drugs, and isolated compounds were dissolved in 100% sterile dimethyl sulfoxide (DMSO) at 20 mg/mL (extracts) or at 20 mM, and serial dilutions were made from this stock. Extract or drug solutions (1 µL) were added to wells in quadruplicate.
Plates were incubated for 72 hours in a humidified 5% CO 2 atmosphere at 37 
